Singapore markets open in 4 hours 45 minutes

Straits Times Index
3,292.69
+10.64(+0.32%)
S&P 500
5,018.39
-17.30(-0.34%)
Dow
37,903.29
+87.37(+0.23%)
Nasdaq
15,605.48
-52.34(-0.33%)
Bitcoin USD
57,024.12
-2,850.35(-4.76%)
CMC Crypto 200
1,196.03
-143.03(-10.68%)

Clinuvel Pharmaceuticals Limited (CUV.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

15.06

+0.01

(+0.07%)

At close: 04:10PM AEST

Loading interactive chart…

Simply Wall St.
Is Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Clinuvel Pharmaceuticals' (ASX:CUV) stock is up by a considerable 8.7% over the past month. Since the market usually...
GlobeNewswire
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE® (afamelanotide) and the future of photomedicine. Over 70 guests discussed the Company’s unique history and future growth potential at an invitation-only event in Düsseldorf. Managing Director and CEO, Dr Philippe Wolgen shared the Company’s success in establishing profitability over the past seven financial years
Simply Wall St.
Clinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 50% loss from investing in the stock three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Clinuvel Pharmaceuticals...